Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4- 216) recognizes nucleophosmin/B23

Prostate

Volumn 39, Issue 4, 1999, Pages 298-304

  Subong, Eric N P ^a   Shue, Matthew J ^a   Epstein, Jonathan I ^a   Briggman, Joseph V ^b   Chan, Pui K ^c   Partin, Alan W ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Matritech Inc   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; NUCLEAR PROTEIN; NUCLEOPHOSMIN;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN DETERMINATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, NUCLEAR; AUTOANTIGENS; BLOTTING, WESTERN; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0033151790     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990601)39:4<298::AID-PROS11>3.0.CO;2-M     Document Type: Article

References (30)

1. Berezney R, Coffey DS. Identification of a nuclear protein matrix. Biochem Biophys Res Commun 1974;60:1410-1417.
2. Partin AW, Getzenberg RH, CarMichael MJ, Vindivich D, Yoo J, Epstein JI, Coffey DS. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res 1993;53:744-746.
3. Getzenberg RH, Pienta KJ, Ward WS, Coffey DS. Nuclear structure and the three-dimensional organization of DNA. J Cell Biochem 1991;47:289-299.
4. Getzenberg RH. Nuclear matrix and the regulation of gene expression: tissue specificity. J Cell Biochem 1994;55:22-31.
5. Partin AW, Briggman JV, Subong EN, Szaro R, Oreper A, Wiesbrock S, Meyer J, Coffey DS, Epstein JI. Preliminary immunohistochemical characterization of a monoclonal antibody (PRO: 4-216) prepared from human prostate cancer nuclear matrix proteins. Urology 1997;50:800-808.
6. Busch H, Lischwe MA, Michalik J, Chan PK, Busch RK. Nucleolar proteins of special interest: silver-staining protein B23 and C23 and antigens of human tumor nucleoli. In: Jordan EG, Cullis CA, editors. The nucleolus, Cambridge, UK: Cambridge University Press; 1982. p 43-71.
7. Schmidt-Zachmann MS, Hugle-Dorr B, Franke WW. A constitutive nucleolar protein identified as a member of the nucleoplasmin family. EMBO J 1987;6:1881-1890.
8. Feuerstein N, Chan PK, Mond JJ. Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. J Biol Chem 1988;263:10608-10612.
9. Derenzini M, Sirri V, Trere D, Ochs RL. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest 1995;73:497-502.
10. Chan WY, Liv QR, Borjigin J, Busch H, Rennert OR, Tease LA, Chan PK. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 1989;28:1033-1039.
11. Roussel P, Hernandez-Verdun D. Identification of Ag-NOR proteins, markers of proliferation related to ribosomal gene activity. Exp Cell Res 1994;214:465-472.
12. Chou YH, Yung BY. Cell cycle phase-dependent changes of localization and oligomerization states of nucleophosmin/B23. Biochem Biophys Res Commun 1995;217:313-325.
13. Spector DL, Ochs RL, Busch H. Silver-staining, immunofluorescence, and immunoelectron microscopic localization of nucleolar phosphoproteins B23 and C23. Chromosoma 1984;90:139-148.
14. Daskal Y, Smetana K, Busch H. Evidence from studies on segregated nucleoli that nucleolar silver staining proteins C23 and B23 are in the fibrillar component. Exp Cell Res 1080;127:285-291.
15. Bocker T, Bittinger A, Wieland W, Buettner R, Fauser G, Hofstaedter F, Ruschoff J. In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate. Mod Pathol 1995;8:226-231.
16. Yung BY, Chan PK. Identification and characterization of a hexameric form of nucleolar phosphoprotein B23. Biochim Biophys Acta 1987;925:74-82.
17. Prestayko AW, Klom GR, Schmoll DJ, Busch H. Comparsion of proteins, ribosomal subunits and nucleolar preribosomal particles from Novikoff hepatoma ascites cells by two-dimensional polyacrylamide gel electrophoresis. Biochemistry 1974;13:1945-1951.
18. Yung BY, Busch H, Chan PK. Effects of luzopeptins on protein B23 translocation and ribosomal RNA synthesis in HeLa cells. Cancer Res 1986;46:922-925.
19. Fankhauser C, Izaurralde E, Adachi Y, Wingfield P, Laemmli UK. Specific complex of human immunodeficiency virus type 1 rev and nucleolar B23 proteins: dissociation by the Rev response element. Mol Cell Biol 1991;11:2567-2575.
20. Dumbar TS, Gentry GA, Olson MO. Interaction of nucleolar phosphoprotein B23 with nucleic acids. Biochemistry 1989;28: 9495-9501.
21. Fey EG, Penman S. Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc Natl Acad Sci USA 1988; 85:121-125.
22. Wray W, Boulikas T, Wray VP, Hancock R. Silver-staining of proteins in polyacrylamide gels. Anal Biochem 1981;118:197-203.
23. Kaufmann SH, Ewing CM, Shaper JH. The erasable Western blot. Anal Biochem 1987;161:89-95.
24. Chan PK, Aldrich M, Busch H. Alterations in immunolocalization of the phosphoprotein B23 in HeLa cells during serum starvation. Exp Cell Res 1985;161:101-110.
25. Mattern KA, Humbel BM, Muijsers AO, de Jong L, van Driel R. hnRNP proteins and B23 are the major proteins of the internal nuclear matrix of HeLa S3 cells. J Cell Biochem 1996;62:275-289.
26. Mattern KA, van Goethem RE, de Jong L, van Driel R. Major internal nuclear matrix proteins are common to different human cell types. J Cell Biochem 1997;65:42-52.
27. Yung BYM, Bor AMS, Yang YH. Immunolocalization of phosphoprotein B23 in proliferating and non-proliferating HELA cells. Int J Cancer 1990;46:272-275.
28. Lakshmanan Y, Subong EN, Partin AW. Differential nuclear matrix protein expression in prostate cancers: correlation with pathologic stage. J Urol 1998;159:1354-1358.
29. Miller TE, Beausang LE, Winchell LF, Lidgard GP. Detection of nuclear matrix proteins in serum from cancer patients. Cancer Res 1992;52:422-427.
30. Keesee SK, Briggman JV, Thill G, Wu YJ. Utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukaryotic Gene Expression 1996;6:189-214.